Abexinostat and Ibrutinib in Diffuse Large B-cell Lymphoma and Mantle Cell Lymphoma

Clinical trial NCT03939182 · COMPLETED

Trial details

NCT number: NCT03939182
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Large B-cell Lymphoma Mantle Cell Lymphoma

Start date: 2019-05-29
Primary completion: 2025-04-22
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.